Quantbot Technologies LP Travere Therapeutics, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$7.64 - $17.25 $764 - $1,725	100 New	100 $0
Q1 2023 May 12, 2023	BUY	$17.82 - $22.89 $297,594 - $382,263	16,700 New	16,700 $375,000
Q2 2022 Aug 09, 2022	BUY	$20.94 - $30.01 $136,110 - $195,065	6,500 New	6,500 $157,000
Q1 2022 May 16, 2022	SELL	$23.61 - $30.6 $8,051 - $10,434	-341 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$24.34 - $31.17 $8,299 - $10,628	341 New	341 $10,000
Q3 2021 Nov 09, 2021	SELL	$12.98 - $25.03 $11,513 - $22,201	-887 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$14.11 - $26.4 $12,515 - $23,416	887 New	887 $12,000

192

84.5M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.12B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.